Published: 2024-03-01
Original Articles
RNF135 promotes cell proliferation and autophagy in lung adenocarcinoma by promoting the phosphorylation of ULK1
Abstract 1086 | PDF Downloads 1398 HTML Downloads 0 XML Downloads 26Page 3-9
Safety of direct oral provocation test to delabel reported mild beta-lactam allergy in infants
Abstract 1101 | PDF Downloads 1134 HTML Downloads 0 XML Downloads 18Page 10-15
Isoegomaketone alleviates inflammatory response and oxidative stress in sepsis lung injury
Abstract 1192 | PDF Downloads 1389 HTML Downloads 0 XML Downloads 30Page 16-22
Association of behaviors and asthma control in a sample of Lebanese adolescents with asthma
Abstract 1257 | PDF Downloads 1301 HTML Downloads 0 XML Downloads 22Page 51-59
YBX-1 alleviates sepsis-stimulated lung epithelial cell injury
Abstract 1256 | PDF Downloads 1338 HTML Downloads 0 XML Downloads 15Page 60-67
Research Article
Are the presence of asthma and the COVID-19 infection associated with behavioral changes in Lebanese adolescents?
Abstract 911 | PDF Downloads 993 HTML Downloads 0 XML Downloads 20Page 68-79
Letter to Editor
Allergic rhinitis: therapeutic strategies update Lactococcus lactis Plasma and tranilast–roxithromycin combination
Abstract 1079 | PDF Downloads 920 HTML Downloads 0 XML Downloads 16Page 1-2
Review Article
Primary, secondary and tertiary prevention of food allergy: current practices and future directions
Abstract 2554 | PDF Downloads 2210 HTML Downloads 0 XML Downloads 207Page 32-44
Case Report
Omalizumab in the treatment of Morbihan syndrome in an adolescent girl – case report and literature review
Abstract 1686 | PDF Downloads 1796 HTML Downloads 0 XML Downloads 106Page 23-31
Cold-induced anaphylaxis triggered by drinking cold water
Abstract 2915 | PDF Downloads 1422 HTML Downloads 0 XML Downloads 511Page 45-47
Allergy to Gibberellin-regulated proteins in an adolescent: A case of orange-induced anaphylaxis mediated by cofactors
Abstract 826 | PDF Downloads 882 HTML Downloads 0 XML Downloads 37Page 48-50
Research Letter
Real-life experience after 3 months with tezepelumab before marketing approval
Abstract 1292 | PDF Downloads 1338 HTML Downloads 0 XML Downloads 87Page 80-82